01 / Vendor Profile
INSTITUTE FOR CANCER RESEARCH, THE Federal Contracts and Awards
UEI FF1XVJMDYVR1 · CAGE 1RAF4
Federal contract activity attributed to this vendor identity across FY 2019–FY 2025. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2019–FY 2025.
Across FY 2019–FY 2025, FPDS records attribute $7.65M in net contract obligations to INSTITUTE FOR CANCER RESEARCH, THE across 38 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
INSTITUTE FOR CANCER RESEARCH, THE contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$0
FY 2025ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2019 | $368.4K | 4 | 1 | — |
| FY 2020 | $804.8K | 3 | 1 | +118.5% |
| FY 2021 | $16.0K | 5 | 1 | −98.0% |
| FY 2022 | $2.55M | 10 | 1 | +15,875.8% |
| FY 2023 | $2.23M | 7 | 1 | −12.7% |
| FY 2024 | $1.69M | 6 | 1 | −24.3% |
| FY 2025 | $0 | 3 | 1 | −100.0% |
04 / Federal Customers
Which federal agencies buy from INSTITUTE FOR CANCER RESEARCH, THE?
Ranked by net obligations during FY 2019–FY 2025.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7529 | $7.65M | 38 | 100.0% |
05 / Contracting Offices
Which contracting offices buy from INSTITUTE FOR CANCER RESEARCH, THE?
Ranked by net obligations during FY 2019–FY 2025.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75N910 | NATIONAL INSTITUTES OF HEALTH | $7.64M | 37 | 99.8% | |
| 75N92E | NATIONAL INSTITUTES OF HEALTH | $16.8K | 1 | 0.2% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $7.26M | 20 | 1 | 94.8% |
| 541711 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY | $335.5K | 12 | 1 | 4.4% |
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | $41.7K | 3 | 1 | 0.5% |
| 541990 | ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES | $25.0K | 1 | 1 | 0.3% |
| 541380 | TESTING LABORATORIES | -$5.5K | 2 | 1 | -0.1% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| AN12 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $7.26M | 20 | 1 | 94.8% |
| AN11 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $335.5K | 12 | 1 | 4.4% |
| AD26 | R&D- DEFENSE OTHER: SERVICES (MANAGEMENT/SUPPORT) | $25.0K | 1 | 1 | 0.3% |
| B529 | SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA | $24.9K | 2 | 1 | 0.3% |
| 6505 | DRUGS AND BIOLOGICALS | $16.8K | 1 | 1 | 0.2% |
| R499 | SUPPORT- PROFESSIONAL: OTHER | -$5.5K | 2 | 1 | -0.1% |
08 / Competition Pattern
How was INSTITUTE FOR CANCER RESEARCH, THE’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for INSTITUTE FOR CANCER RESEARCH, THE?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 75N91022F00002 | Jul 14, 2025 | $0 | NATIONAL INSTITUTES OF HEALTH NIH NCI | 541714 | AN12 |
10 / Interpreting the Profile
How should you evaluate INSTITUTE FOR CANCER RESEARCH, THE as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.